<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>182(1)</volume><submitter>Swaminathan L</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>Peripherally inserted central catheters (PICCs) and midlines are frequently used for short-term venous access; whether one is safer than the other in this setting has not been adequately reported.&lt;h4>Objective&lt;/h4>To compare outcomes between patients who had a PICC vs midline placed for the indication of difficult vascular access or antibiotic therapy for 30 or fewer days.&lt;h4>Design, setting, and participants&lt;/h4>This cohort study analyzed data from a multihospital registry including patients admitted to a participating site from December 2017 through January 2020 who had a PICC or midline placement for the indications of difficult venous access or intravenous antibiotic therapy prescribed for 30 or fewer days. Data were analyzed from October 2020 to March 2021.&lt;h4>Expos</pubmed_abstract><journal>JAMA internal medicine</journal><pagination>50-58</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8630646</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Safety and Outcomes of Midline Catheters vs Peripherally Inserted Central Catheters for Patients With Short-term Indications: A Multicenter Study.</pubmed_title><pmcid>PMC8630646</pmcid><pubmed_authors>Flanders S</pubmed_authors><pubmed_authors>O'Malley M</pubmed_authors><pubmed_authors>Horowitz J</pubmed_authors><pubmed_authors>Chopra V</pubmed_authors><pubmed_authors>Swaminathan L</pubmed_authors><pubmed_authors>Zhang Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Safety and Outcomes of Midline Catheters vs Peripherally Inserted Central Catheters for Patients With Short-term Indications: A Multicenter Study.</name><description>&lt;h4>Importance&lt;/h4>Peripherally inserted central catheters (PICCs) and midlines are frequently used for short-term venous access; whether one is safer than the other in this setting has not been adequately reported.&lt;h4>Objective&lt;/h4>To compare outcomes between patients who had a PICC vs midline placed for the indication of difficult vascular access or antibiotic therapy for 30 or fewer days.&lt;h4>Design, setting, and participants&lt;/h4>This cohort study analyzed data from a multihospital registry including patients admitted to a participating site from December 2017 through January 2020 who had a PICC or midline placement for the indications of difficult venous access or intravenous antibiotic therapy prescribed for 30 or fewer days. Data were analyzed from October 2020 to March 2021.&lt;h4>Expos</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2025-04-21T16:07:56.464Z</modification><creation>2025-04-21T16:07:56.464Z</creation></dates><accession>S-EPMC8630646</accession><cross_references><pubmed>34842905</pubmed><doi>10.1001/jamainternmed.2021.6844</doi></cross_references></HashMap>